According to ANI Pharmaceuticals's latest financial reports the company's current earnings are โฌ0.55 Billion. In 2023 the company made an earning of โฌ19.18 Million, an increase over its 2022 earnings that were of -โฌ60.5 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -โฌ6.02 Million | -131.36% |
2023 | โฌ19.18 M | -131.71% |
2022 | -โฌ60.5 Million | 11.79% |
2021 | -โฌ54.12 Million | 115.92% |
2020 | -โฌ25.07 Million | -922.36% |
2019 | โฌ3.04 M | -84.26% |
2018 | โฌ19.35 M | 22.64% |
2017 | โฌ15.78 M | 88.4% |
2016 | โฌ8.37 M | -60.07% |
2015 | โฌ20.98 M | 12.15% |
2014 | โฌ18.7 M | -899.29% |
2013 | -โฌ2.35 Million | -91.27% |
2012 | -โฌ26.81 Million | -46.02% |
2011 | -โฌ49.67 Million | 17.96% |
2010 | -โฌ42.1 Million | 18% |
2009 | -โฌ35.68 Million | 103.96% |
2008 | -โฌ17.5 Million | 128.68% |
2007 | -โฌ7.65 Million | -330.34% |
2006 | โฌ3.32 M | -136.98% |
2005 | -โฌ8.99 Million | -24.17% |
2004 | -โฌ11.85 Million | 102.51% |
2003 | -โฌ5.85 Million | 58.68% |
2002 | -โฌ3.69 Million | 39.58% |
2001 | -โฌ2.65 Million | -24.1% |
2000 | -โฌ3.48 Million |